On Friday, TELA Bio Inc (NASDAQ: TELA) was -7.69% drop from the session before settling in for the closing price of $1.17. A 52-week range for TELA has been $1.14 – $6.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 35.99% over the past five years. When this article was written, the company’s average yearly earnings per share was at 51.13%. With a float of $31.78 million, this company’s outstanding shares have now reached $39.40 million.
Let’s look at the performance matrix of the company that is accounted for 209 employees. In terms of profitability, gross margin is 67.08%, operating margin of -60.17%, and the pretax margin is -54.81%.
TELA Bio Inc (TELA) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward TELA Bio Inc stocks. The insider ownership of TELA Bio Inc is 19.65%, while institutional ownership is 61.51%. The most recent insider transaction that took place on Oct 24 ’24, was worth 144,999. In this transaction COO and CFO of this company bought 64,444 shares at a rate of $2.25, taking the stock ownership to the 155,388 shares. Before that another transaction happened on Oct 24 ’24, when Company’s Chief Technology Officer bought 22,222 for $2.25, making the entire transaction worth $50,000. This insider now owns 91,082 shares in total.
TELA Bio Inc (TELA) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 51.13% per share during the next fiscal year.
TELA Bio Inc (NASDAQ: TELA) Trading Performance Indicators
You can see what TELA Bio Inc (TELA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.19. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.39, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.37 in one year’s time.
Technical Analysis of TELA Bio Inc (TELA)
TELA Bio Inc (NASDAQ: TELA) saw its 5-day average volume 0.57 million, a positive change from its year-to-date volume of 0.27 million. As of the previous 9 days, the stock’s Stochastic %D was 13.47%. Additionally, its Average True Range was 0.18.
During the past 100 days, TELA Bio Inc’s (TELA) raw stochastic average was set at 3.54%, which indicates a significant decrease from 5.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 193.82% in the past 14 days, which was higher than the 90.03% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.2715, while its 200-day Moving Average is $3.0052. Nevertheless, the first resistance level for the watch stands at $1.1600 in the near term. At $1.2400, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.3200. If the price goes on to break the first support level at $1.0000, it is likely to go to the next support level at $0.9200. The third support level lies at $0.8400 if the price breaches the second support level.
TELA Bio Inc (NASDAQ: TELA) Key Stats
There are 39,388K outstanding shares of the company, which has a market capitalization of 42.72 million. As of now, sales total 69,300 K while income totals -37,840 K. Its latest quarter income was 17,650 K while its last quarter net income were -9,210 K.
